Moderna just reminded the market why biotech can move so violently.
$MRNA surged nearly 177% after Moderna and Merck reported positive Phase 3 results for their personalized mRNA cancer treatment.
The therapy hit key endpoints linked to melanoma recurrence and cancer spread.
And now $BEAT is another one to watch as investors continue looking for the next major breakthrough in biotech.
The bigger picture is clear: mRNA technology is being pushed far beyond vaccines, with cancer treatment emerging as one of its biggest potential frontiers.
#BingX #BEAT #Crypto
$MRNA surged nearly 177% after Moderna and Merck reported positive Phase 3 results for their personalized mRNA cancer treatment.
The therapy hit key endpoints linked to melanoma recurrence and cancer spread.
And now $BEAT is another one to watch as investors continue looking for the next major breakthrough in biotech.
The bigger picture is clear: mRNA technology is being pushed far beyond vaccines, with cancer treatment emerging as one of its biggest potential frontiers.
#BingX #BEAT #Crypto